Results 21 to 30 of about 3,711,986 (271)

Pneumonia: Regional experience with prevention programs [PDF]

open access: yesТерапевтический архив, 2016
Aim. To generalize the regional experience in implementing a package of organizational and methodical and antiepidemic measures for preventing pneumococcal infections. Materials and methods.
A G Chuchalin   +7 more
doaj   +1 more source

The Roles of Transient Receptor Potential Vanilloid 1 and 4 in Pneumococcal Nasal Colonization and Subsequent Development of Invasive Disease

open access: yesFrontiers in Immunology, 2021
Transient receptor potential (TRP) channels, neuronal stimulations widely known to be associated with thermal responses, pain induction, and osmoregulation, have been shown in recent studies to have underlying mechanisms associated with inflammatory ...
Masamitsu Kono   +13 more
doaj   +1 more source

In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection [PDF]

open access: yes, 2019
An overt pro-inflammatory immune response is a key factor contributing to lethal pneumococcal infection in an influenza pre-infected host and represents a potential target for therapeutic intervention.
Boehme, Julia D.   +8 more
core   +1 more source

Coinfection of Leishmania (Viannia) braziliensis and Streptococcus pneumoniae in multiple cutaneous lesions [PDF]

open access: yes, 2016
Key learning points Cutaneous leishmaniasis is the most common clinical disease caused by all the Leishmania species that are pathogenic to humans. Other bacterial coinfections of Leishmania lesions have been described, but this is the first report of ...
Chiapello, Laura Silvina   +6 more
core   +2 more sources

House Dust Mite Aeroallergen Suppresses Leukocyte Phagocytosis and Netosis Initiated by Pneumococcal Lung Infection

open access: yesFrontiers in Pharmacology, 2022
Asthmatics are highly susceptible to developing lower respiratory tract infections caused by Streptococcus pneumoniae (SPN, the pneumococcus). It has recently emerged that underlying allergic airway disease creates a lung microenvironment that is ...
Angelica Papanicolaou   +9 more
doaj   +1 more source

Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic

open access: yesInternational Journal of Infectious Diseases, 2019
Objectives: The aim of this study was to estimate the impact of antimicrobial resistance (AMR) in secondary pneumococcal pneumonia infections on global mortality during the 2009 influenza pandemic, to estimate future pandemic mortality risk and to inform
Carrie E. Barnes, C. Raina MacIntyre
doaj   +1 more source

Impact of infection preventionists on Centers for Medicare and Medicaid quality measures in Maryland nursing homes. [PDF]

open access: yes, 2014
BackgroundHealth care-associated infections are the leading cause of morbidity and mortality in US nursing homes (NHs). The objective of the research is to assess the impact of Maryland NH infection preventionists (IPs) on NH quality measures.MethodsTwo ...
Castle, Nicholas G   +2 more
core   +1 more source

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective

open access: yesBMC Infectious Diseases, 2012
Background The burden of invasive pneumococcal disease in young children decreased dramatically following introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). The epidemiology of S.
Weil-Olivier Catherine   +4 more
doaj   +1 more source

New Vaccines for the Prevention of Pneumococcal Infections

open access: yesEmerging Infectious Diseases, 1996
Streptococcus pneumoniae is a major cause of acute otitis media, pneumonia, bacteremia, and meningitis. Because in recent years antibiotic-resistant pneumococcal strains have been emerging throughout the world, vaccination against pneumococcal infections
Helena Käyhty, Juhani Eskola
doaj   +1 more source

Pneumococcal serotypes in children in 4 European countries [PDF]

open access: yes, 2010
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and England and Wales (United Kingdom), invasive disease from non-PCV7 serotypes (NVT) increased. Adjusted serotype-specific incidences among children
Fenoll, Asuncion   +8 more
core   +3 more sources

Home - About - Disclaimer - Privacy